SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-21-002837
Filing Date
2021-07-06
Accepted
2021-07-06 16:00:13
Documents
4
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K sonoma_8k.htm 8-K 37041
2 EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND AMY TROMBLY, DATED JULY 1, 2 sonoma_ex1001.htm EX-10.1 131038
3 EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND JERRY DVONCH, DATED JULY 1, sonoma_ex1002.htm EX-10.2 130511
4 EMPLOYMENT AGREEMENT BY AND BETWEEN THE COMPANY AND BRUCE THORNTON, DATED JULY 1 sonoma_ex1003.htm EX-10.3 139583
  Complete submission text file 0001683168-21-002837.txt   439490
Mailing Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189
Business Address 645 MOLLY LANE, SUITE 150 WOODSTOCK GA 30189 800-759-9305
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 211074011
SIC: 2834 Pharmaceutical Preparations